Guardian Pharmacy Services’ (NYSE:GRDN – Get Free Report) lock-up period is set to expire on Tuesday, March 25th. Guardian Pharmacy Services had issued 8,000,000 shares in its public offering on September 26th. The total size of the offering was $112,000,000 based on an initial share price of $14.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
Guardian Pharmacy Services Price Performance
Shares of NYSE GRDN opened at $21.91 on Thursday. Guardian Pharmacy Services has a 52-week low of $14.16 and a 52-week high of $25.74. The company’s fifty day moving average is $20.49.
Hedge Funds Weigh In On Guardian Pharmacy Services
A number of institutional investors have recently added to or reduced their stakes in GRDN. Royce & Associates LP acquired a new stake in Guardian Pharmacy Services during the third quarter worth about $1,260,000. Foundry Partners LLC bought a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $1,680,000. Maven Securities LTD bought a new stake in Guardian Pharmacy Services during the third quarter worth approximately $3,033,000. Point72 DIFC Ltd purchased a new stake in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $573,000. Finally, Wellington Management Group LLP purchased a new stake in shares of Guardian Pharmacy Services in the 3rd quarter valued at approximately $8,400,000.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Stock Market Upgrades: What Are They?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.